drugset / Trial / NCT01516086

A 12-Week Study in Adult Subjects With Asthma

NCT01516086

Phase 2 Completed 498 enrolled Dey
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This will be a multi-center, randomized, placebo controlled parallel-group study to Replicate Efficacy of Nebulized Fluticasone Propionate (FP) in Adult Subjects with Partly Controlled and Uncontrolled Asthma. Individual participation will be approximately 16 weeks, including 12 weeks of double-blind treatment.

Timeline

Start
2012-03
Primary completion
2013-11
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone propionate Other / unclassified Inhaled

Indications